Bicycle Therapeutics Earning Date (BCYC)

USA |NASDAQ |USD |ADR

BCYC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - $-0.93 $-0.74
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $1.78M

Bicycle Therapeutics's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

BCYC Earnings Date & History Chart

BCYC Earnings & Revenue Forecast

BCYC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $-3.07 $-4.61 $-0.71

BCYC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 2 $-2.95 $-2.97 $-3.42

BCYC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $19.41M $7.14M $67.01M

BCYC Earnings Date & Revenue History

BCYC Earnings History

|
Show More
Show More

BCYC Revenue History

|
Show More
Show More

Bicycle Therapeutics Next Earnings Date & Report

BCYC Next Earnings Date & Report Preview: Jun 2022 (FQ)

BCYC's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

The average EPS estimation for Bicycle Therapeutics's next quarterly earnings is $-0.74.

Bicycle Therapeutics Previous Earnings Dates & Reports

BCYC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Bicycle Therapeutics's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

BCYC's earnings per share (EPS) was $-0.93, missing the consensus analysts forecast of $-0.68 by -36.76%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 47.62%, and lower than the same period a year before (Mar 2021) by 27.40%.

The company reported a net income of $-27.56B.

Free cash flow for the quarter was $-31.16M , compared to $-11.50M last quarter and $-14.33M a year before.

BCYC ended the quarter with $44.10M in total debt, a decrease of -0.53% compared to the previous quarter, and an increase of 32.71% compared to the same quarter a year before.

BCYC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Bicycle Therapeutics's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.

BCYC's earnings per share (EPS) was $-2.69, beating the consensus analysts forecast of $-2.79 by -3.58% , and lower than the previous year's EPS (Dec 2020) by 1.51%.

Revenues were $11.70M, worse than the forecast of $14.13M by -17.22%, and up by 12.58% from previous year's revenue.

The company reported a net income of $-66.82M.

Bicycle Therapeutics reported a free cash flow of $-16.82M for its fiscal year, compared to $-18.99M a year ago.

The company ended the fiscal year with $44.34M in total debt, an increase of 181.06% compared to the previous year.